EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Utility of dynamic 18F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma

Kevin Jang iD, Patrick Horsley, Dale Bailey, Edward Hsiao, Geoffrey Schembri, James Drummond, Elizabeth Bailey, Michael Rodriguez, Helen Wheeler, Michael Back iD

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 02.04.2026. Verfasst von Kevin Jang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Distinguishing early recurrence from pseudoprogression after chemoradiotherapy remains a major challenge in glioblastoma. Although 18-F-fluroethyl-L-tyrosine (FET)-PET is increasingly used, reliance on static thresholds limits accuracy in the early post-radiotherapy period. The role of dynamic time-activity-curve (TAC) patterns in this setting is not well defined. We evaluated the diagnostic and prognostic performance of TAC morphology compared with static uptake metrics.

Methods

Sixty-six patients with glioblastoma underwent FET-PET within 6 months of radiotherapy. Final diagnosis was determined by histopathology (n = 15) or predefined clinical endpoints (n = 51). Static metrics (SUVmax, TBRmax) and dynamic TAC morphology (Types 1-3) were assessed. Diagnostic performance was assessed by receiver-operating-characteristic analysis, logistic regression, and sensitivity analyses. Overall survival (OS) was analyzed with Kaplan-Meier and Cox regression.

Results

Thirty-five patients (53%) had recurrence and 31 (47%) pseudoprogression. TAC morphology demonstrated the highest diagnostic accuracy (AUC 0.76; sensitivity 68.8%; specificity 94.7%; PPV 93.6%; NPV 72.9%), outperforming SUVmax (AUC 0.66) and TBRmax (AUC 0.57). TAC morphology was the sole independent predictor of recurrence (OR 4.62; P = .010). Median OS was significantly shorter in recurrence compared with pseudoprogression (10.2 vs 20.5 months; P < .0001). TAC type stratification revealed median OS of 11.7 months (Type 1), 9.9 months (Type 2), and 8.8 months (Type 3; log-rank P = .041). Sensitivity analysis excluding patients with diagnostically ambiguous ground truth (n = 14) confirmed that TAC pattern remained a significant predictor of diagnosis (AUC 0.75; P = .012).

Conclusions

Dynamic FET-PET improves diagnostic specificity and provides prognostic insight beyond static uptake metrics. TAC patterns offer a structured framework for improving diagnostic certainty and guiding therapeutic decisions.

Schlagwörter

Stichwörter der Autor:innen

FET PETdynamic imagingglioblastomapseudoprogressiontumor recurrence

Autor:innen und Institutionen

  • Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Department of Nuclear Medicine, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Department of Radiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Department of Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • The Brain Cancer Group, Sydney, New South Wales, Australia.

ORCID-Profile: Kevin Jang, Michael Back

Zitieren

APA

Jang, K., Horsley, P., Bailey, D., Hsiao, E., Schembri, G., Drummond, J., Bailey, E., Rodriguez, M., Wheeler, H., & Back, M. (2026). Utility of dynamic 18F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag085

Vancouver

Jang K, Horsley P, Bailey D, Hsiao E, Schembri G, Drummond J, et al. Utility of dynamic 18F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag085

BibTeX
@article{Jang2026,
  author = {Jang, Kevin and Horsley, Patrick and Bailey, Dale and Hsiao, Edward and Schembri, Geoffrey and Drummond, James and Bailey, Elizabeth and Rodriguez, Michael and Wheeler, Helen and Back, Michael},
  title = {Utility of dynamic 18F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag085}
}
Kostenlos starten →